On Wednesday, July 29, SpaceX (SPCX) shares fell 3.32%, closing at $112.55. This decline occurred despite a major $1.6 billion contract with the U.S. Space Force, which includes 18 Falcon 9 launches through 2027. At first glance, this seems like a classic market paradox, but upon closer inspection, it all makes sense.

The drop in quotes is a continuation of a negative trend that began almost immediately after SpaceX's debut on the Nasdaq. The offering price was $135 per share. After that, the stock soared to a record $225.64 in mid-June, but then a sharp correction followed. Over the past month, shares have lost about 29% of their value. The day before, an intraday low of $107.01 was updated — the stock is now trading significantly below the initial offering price.

The contract didn't help: what's the reason?

The market, as is well known, looks ahead. The $1.6 billion contract is undoubtedly a positive signal from a long-term revenue perspective. However, investors are currently concerned about two factors: the stock lockup expiration on August 6 and the release of the financial report on August 4. The lockup expiration could significantly increase the supply of shares on the market, creating additional downward pressure on the price. Essentially, the market is pricing in this risk in advance.

We cannot ignore the broader context either. SpaceX's competitors — ULA and Blue Origin — continue to face technical difficulties. ULA is still dealing with a booster separation issue on the Vulcan rocket, while Blue Origin is investigating an explosion at the launch pad that has halted New Glenn launches. This undoubtedly strengthens SpaceX's dominant position in the eyes of the Pentagon, but it has little impact on the stock's short-term dynamics.

Deal details and strategic context

The new order is part of the National Security Space Launch Phase 3 Lane 1 program. It involves launching satellites into orbit to detect and track aerial threats under the Pentagon's Space Based Sensing and Targeting program. This contract complements SpaceX's May victory, when the company received a $6.5 billion order for military satellites. Thus, the company's total military contracts this year already exceed $7 billion.

Interestingly, a significant portion of these orders is tied to the massive $185 billion Golden Dome missile defense program, approved during the Trump administration. This is a strategic asset that will keep SpaceX busy for years to come.

My analysis

The paradox of "good news — falling stocks" is typical for markets undergoing a period of revaluation. In SpaceX's case, we see a classic scenario: investors are taking profits after a strong rally and preparing for a potential increase in share supply. Fundamentally, the company is stronger than ever, but the short-term technical picture remains bearish. The key moment will come after August 6 — if the lockup expiration does not trigger a collapse, we can talk about a bottom forming. For now, I recommend caution.